XBI

Ss Spdr S&p Biotech ETF

-$3.0B

Net Activity

Institutions Holding

839

Popularity Rank

#572

Avg Weight

0.45%

Total Value

$20.9B

Ownership Trend

839 institutions currently hold XBI, with 357 net buyers and 358 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

358

Net Buying Institutions

357

Key Holders

View all 839 holding institutions

Quarterly Activity

Recent Activity

+$11.0B

Total Buy Value

$17.3B

Total Sell Value

New buy106
Trim261
Add251
Sold out97

357

Net Buyers

358

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding SS SPDR S&P BIOTECH ETF (XBI)?
Major stakeholders currently include Bank Of America CORP /de/ ($1.9B), Goldman Sachs Group INC ($1.8B), Morgan Stanley ($1.6B). Based on the latest 13F filings, there are a total of 839 tracked investment funds and institutions maintaining positions in XBI.
What is the overall institutional sentiment toward XBI recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $3.0B, driven by 357 managers accumulating shares while 358 reduced their exposure.
Which institutions have been selling or reducing their XBI positions?
In the latest period, 261 funds trimmed their holdings, and 97 managers completely exited their positions. The aggregate reported sell value was $17.3B.
Are there any notable investors adding XBI to their portfolios?
Yes, buying activity remains notable. 106 institutions opened new positions in {ticker}, and 251 existing holders added to their shares. The total reported buy value for the quarter amounted to $11.0B.

Related Stocks